Dividend Overview
Dividend Yield
2.80%
Dividend / Share
$4.10
Novartis AG
Exchange: NYSESector: HealthcareIndustry: Drug Manufacturers - General
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people's lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach nearly 300 million people worldwide.
Did you know?
Profit margin of 23.9% — that's well above average.
Current Price
$146.57
-0.87%GoodMoat Value
$194.53
32.7% undervaluedProfile
Valuation (TTM)
Market Cap$279.68B
P/E20.66
EV—
P/B6.06
Shares Out1.91B
P/Sales4.94
Revenue$56.58B
EV/EBITDA11.41
Novartis AG (NVS) Dividends
Key Metrics
Market Cap
$279.68B
P/E Ratio
20.66
Forward P/E
—
EPS
$7.15
PEG Ratio
-2.10
Book Value
$24.18
Dividend Yield
2.80%
Profit Margin
23.92%
ROE
29.34%
Dividend History
Dividend Safety
NVS Dividend Analysis
Novartis AG (NVS) dividend analysis including yield, payout history, and sustainability metrics. The current dividend yield is 2.80%. The annual dividend per share is $4.10.
P/E ratio: 20.66. Profit margin: 23.92%. Free cash flow: $17.61B. This page shows Novartis AG's dividend overview, key metrics, historical payout data, and dividend safety assessment to help income-focused investors evaluate the sustainability of dividend payments.
GoodMoat's dividend analyzer evaluates payout ratios, earnings coverage, and free cash flow coverage to determine how well supported Novartis AG's dividend payments are. Use this analysis alongside the company's financial statements and quality score to make informed income-investing decisions.